Kling-Petersen T, Ljung E, Wollter L, Svensson K
Department of Pharmacology, University of Göteborg, Sweden.
J Neural Transm Gen Sect. 1995;101(1-3):27-39. doi: 10.1007/BF01271543.
Compounds showing an in vitro binding preference for the dopamine D3 receptor were tested in two models designed to assess positive reinforcement in the rat: intracranial self-stimulation (ICSS) and conditioned place preference (CPP). R-(+)-7-OH-DPAT, a D3 preferring agonist, inhibited ICSS behaviour over a wide dose range. At higher doses, a facilitation of ICSS was seen. In the CPP model, 7-OH-DPAT was inactive except at the highest dose where a significant change in preference was seen. A dose of R-(+)-7-OH-DPAT, that significantly inhibited ICSS behaviour, was combined with a dose of d-amphetamine, that significantly facilitated ICSS behaviour. Surprisingly, this resulted in a significant synergistic facilitation of the amphetamine response. The putative D3 antagonist, U99194A was inactive in the ICSS model but induced significant place preference. The present results suggest that the dopamine D3 receptor, in contrast to the D2 receptor, has an inhibitory influence on reward mechanisms.
对在体外对多巴胺D3受体显示出结合偏好的化合物,在旨在评估大鼠阳性强化作用的两种模型中进行了测试:颅内自我刺激(ICSS)和条件性位置偏好(CPP)。R-(+)-7-羟基-DPAT是一种优先作用于D3的激动剂,在很宽的剂量范围内抑制ICSS行为。在较高剂量时,观察到ICSS行为增强。在CPP模型中,7-羟基-DPAT无活性,除非在最高剂量时观察到偏好有显著变化。将显著抑制ICSS行为的R-(+)-7-羟基-DPAT剂量与显著增强ICSS行为的右旋苯丙胺剂量相结合。令人惊讶的是,这导致苯丙胺反应显著协同增强。推定的D3拮抗剂U99194A在ICSS模型中无活性,但诱导了显著的位置偏好。目前的结果表明,与D2受体相反,多巴胺D3受体对奖赏机制有抑制作用。